Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

ATP5L Inhibitors

ATP5L inhibitors are a class of chemical compounds that specifically target and inhibit the function of the ATP5L subunit, a component of the mitochondrial ATP synthase complex. ATP5L, also known as subunit g, is integral to the assembly and stability of ATP synthase, which is responsible for the production of ATP through oxidative phosphorylation. This complex resides in the inner mitochondrial membrane and plays a critical role in cellular energy metabolism. By inhibiting ATP5L, these compounds interfere with the structural integrity of ATP synthase, disrupting the process of ATP production. This reduction in ATP synthesis affects the cell's energy balance, making ATP5L inhibitors important tools for studying mitochondrial function and energy metabolism.

Inhibition of ATP5L allows researchers to investigate the role of ATP synthase in cellular energy production and its broader impact on cellular processes that rely on ATP. By blocking the activity of this subunit, scientists can examine how changes in mitochondrial ATP output affect processes such as metabolic flux, ion transport, and maintenance of membrane potential. These inhibitors also provide insights into the assembly and stability of the ATP synthase complex, as ATP5L plays a key role in ensuring the proper organization of the entire enzyme complex. Through the use of ATP5L inhibitors, researchers can explore the intricate relationship between mitochondrial function and cellular energy demands, enhancing the understanding of how mitochondria regulate energy production and its effects on overall cell physiology. These inhibitors are thus valuable tools in the study of bioenergetics and mitochondrial biology.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D binds to DNA and inhibits RNA polymerase, which can prevent the transcription of ATP5L.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A is an HDAC inhibitor, leading to hyperacetylation of histones, potentially repressing ATP5L gene expression by altering chromatin structure.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This DNA methyltransferase inhibitor may cause hypomethylation of the ATP5L gene, potentially silencing its expression.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

By inhibiting RNA polymerase II, α-Amanitin can suppress mRNA synthesis, thus inhibiting ATP5L transcription.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$97.00
$328.00
$676.00
$1467.00
6
(1)

Rifampicin can inhibit bacterial RNA polymerase, and while not directly applicable to eukaryotic cells, it may theoretically affect mitochondrial RNA polymerase.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

DRB inhibits RNA polymerase II, potentially decreasing ATP5L mRNA synthesis.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine can raise endosomal pH and potentially interfere with signaling pathways that regulate ATP5L expression.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

This compound can bind to GC-rich sequences and might inhibit the transcription of ATP5L if its promoter has such sequences.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

By inhibiting topoisomerase I, camptothecin results in DNA damage, which could indirectly downregulate ATP5L expression as part of a cellular stress response.

Rocaglamide

84573-16-0sc-203241
sc-203241A
sc-203241B
sc-203241C
sc-203241D
100 µg
1 mg
5 mg
10 mg
25 mg
$275.00
$474.00
$1639.00
$2497.00
$5344.00
4
(1)

Rocaglamide inhibits translation initiation and might suppress the synthesis of the ATP5L protein, indirectly reducing its expression.